Giyilebilir Kardiyak Defibrilatör
Özet
Referanslar
Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 2022;43(40):3997-4126. doi: 10.1093/eurheartj/ehac262
Stecker EC, Reinier K, Marijon E, et al. Public health burden of sudden cardiac death in the United States. Circ Arrhythm Electrophysiol 2014;7:212–217.
Zabel M, Willems R, Lubinski A, Bauer A, et al. Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study. Eur Heart J 2020;41:3437–3447
Masri A, Altibi AM, Erqou S, et al. Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death: A Systematic Review and Meta-Analysis. JACC Clin Electrophysiol 2019;5(2):152-61. doi: 10.1016/j.jacep.2018.11.011
Nguyen E, Weeda ER, Kohn CG, et al. Wearable Cardioverter-defibrillators for the Prevention of Sudden Cardiac Death: A Meta-analysis. J Innov Card Rhythm Manag 2018;9(5):3151-62. doi: 10.19102/icrm.2018.090506
Feldman AM, Klein H, Tchou P, et al. Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: results of the WEARIT/BIROAD. Pacing Clin Electrophysiol 2004;27(1):4-9. doi: 10.1111/j.1540-8159.2004.00378.x
Kutyifa V, Moss AJ, Klein HU, McNitt S, Zareba W, Goldenberg I. One-year follow-up of the prospective registry of patients using the wearable defibrillator (WEARIT-II Registry) Pacing Clin Electrophysiol. 2018;41(10):1307–1313. doi: 10.1111/pace.13448.
Olgin JE, Pletcher MJ, Vittinghoff E, et al. Wearable Cardioverter-Defibrillator after Myocardial Infarction. N Engl J Med 2018;379(13):1205-15. doi: 10.1056/NEJMoa1800781
Referanslar
Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 2022;43(40):3997-4126. doi: 10.1093/eurheartj/ehac262
Stecker EC, Reinier K, Marijon E, et al. Public health burden of sudden cardiac death in the United States. Circ Arrhythm Electrophysiol 2014;7:212–217.
Zabel M, Willems R, Lubinski A, Bauer A, et al. Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study. Eur Heart J 2020;41:3437–3447
Masri A, Altibi AM, Erqou S, et al. Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death: A Systematic Review and Meta-Analysis. JACC Clin Electrophysiol 2019;5(2):152-61. doi: 10.1016/j.jacep.2018.11.011
Nguyen E, Weeda ER, Kohn CG, et al. Wearable Cardioverter-defibrillators for the Prevention of Sudden Cardiac Death: A Meta-analysis. J Innov Card Rhythm Manag 2018;9(5):3151-62. doi: 10.19102/icrm.2018.090506
Feldman AM, Klein H, Tchou P, et al. Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: results of the WEARIT/BIROAD. Pacing Clin Electrophysiol 2004;27(1):4-9. doi: 10.1111/j.1540-8159.2004.00378.x
Kutyifa V, Moss AJ, Klein HU, McNitt S, Zareba W, Goldenberg I. One-year follow-up of the prospective registry of patients using the wearable defibrillator (WEARIT-II Registry) Pacing Clin Electrophysiol. 2018;41(10):1307–1313. doi: 10.1111/pace.13448.
Olgin JE, Pletcher MJ, Vittinghoff E, et al. Wearable Cardioverter-Defibrillator after Myocardial Infarction. N Engl J Med 2018;379(13):1205-15. doi: 10.1056/NEJMoa1800781
